Processing speed can monitor stimulant-medication effects in adults with attention deficit disorder with hyperactivity

References

• Biederman J, Faraone SV, Spencer T, Mick E, Monuteaux M, Aleardi M. Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Clin Psychiatry 2006;67:524–40.
   PubMed Web of Science ®Google Scholar
• Huss M, Ginsberg Y, Arngrim T, Phillipsen A, Carter K, Chen CW, et al. Open-label dose optimization of methylphenidate modified release long acting (MPH-LA): A post hoc analysis of real-life titration from a 40-week randomized trial. Clin Drug Investig 2014;34:639–49.
   PubMed Web of Science ®Google Scholar
• Maneeton N, Maneeton B, Intaprasert S, Woottiluk P. A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder. Neuropsychiatry Dis Treat 2014;10:1439–49.
   PubMed Web of Science ®Google Scholar
• Matte B, Anselmi L, Salum GA, Kieling C, Gonçalves H, Menezes A, et al. ADHD in DSM-5: A field trial in a large, representative sample of 18- to 19-year-old adults. Psychol Med 2015;45:361–73.
   PubMed Web of Science ®Google Scholar
• Weiss M, Tannock R, Kratochvil C, Dunn D, Velez-Borras J, Thomason C, et al. A randomized, placebo-controlled study of once-daily Atomoxetine in the school setting in children with ADHD. J Am Acad Child Adolesc Psychiatry 2005;44:647–55.
   PubMed Web of Science ®Google Scholar
• Surman C, Hammerness P, Petty C, Doyle R, Chu N, Gebhard N, et al. Atomoxetine in the treatment of adults with subthreshold and/or late onset attention-deficit hyperactivity disorder-not otherwise specified (ADHD-NOS): A prospective open-label 6-week study. CNS Neurosci Ther 2010;16:6–12.
   PubMed Web of Science ®Google Scholar
• Asherson P, Bushe C, Saylor K, Tanaka Y, Deberdt W, Upadhyaya H. Efficacy of Atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trials. J Psychopharmacol 2014;28:837–46.
   PubMed Web of Science ®Google Scholar
• Weyandt LL, Oster DR, Marraccini ME, Gudmundsdottir BG, Monro BA, Zavras BM, et al. Pharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulants. Psychol Res Behav Manag 2014;7:223–49.
   PubMedGoogle Scholar
• Nylander L, Holmqvist M, Gustafson L, Gilberg C. ADHD in adult psychiatry. Minimum rates and clinical presentation in general psychiatry outpatients. Nord J Psychiatry 2009;63:64–71.
   PubMed Web of Science ®Google Scholar
• Pehlivanidis A, Papanikolaou K, Spyropoulou A, Papadimitriou G. Comorbid attention-deficit/hyperactivity disorder in adult psychiatric outpatients with depressive or anxiety disorders. Int J Psychiatry Clin Pract 2014;18:265–71.
   PubMed Web of Science ®Google Scholar
• Bedard AC, Ickowicz A, Tannock R. Methylphenidate improves Stroop naming speed, but not response interference, in children with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 2002;12:301–9.
   PubMed Web of Science ®Google Scholar
• Söderstöm S, Pettersson R, Nilsson KW. Quantitative and subjective behavioural aspects in the assessment of attention-deficit hyperactivity disorder (ADHD) in adults. Nord J Psychiatry 2014;68:30–7.
   PubMed Web of Science ®Google Scholar
• Bedard AC, Jain U, Johnson SH, Tannock R. Effects of methylphenidate on working memory components: Influence of measurement. J Child Psychol Psychiatry 2007;48:872–80.
   PubMed Web of Science ®Google Scholar
• Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: Exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry 2013;70:185–98.
   PubMed Web of Science ®Google Scholar
• Halleland HB, Haavik J, Lundervold AJ. Set-shifting in adults with ADHD. J Int Neuropsychol Soc 2012;18:728–37.
   PubMed Web of Science ®Google Scholar
• Advokat C. What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD). Neurosci Biobehav Rev 2010;34:1256–66.
   PubMed Web of Science ®Google Scholar
• Krukov P, Karakula-Juchnowicz H, Juchnowicz D, Moylowski-Topolske J, Flis M, Jonak K. Processing speed is associated with differences in IQ and cognitive profiles between patients with schizophrenia and their healthy siblings. Nord J Psychiatry 2016;71:33–41.
   PubMed Web of Science ®Google Scholar
• Wiig EH, Nielsen NP, Minthon L, Warkentin S. A quick test of cognitive speed. Et Kort Manual. Svensk Version & Norsk Versjon. Stockholm, Sweden: Harcourt/PsychCorp; 2005.
   Google Scholar
• Wiig EH, Nielsen NP, Jacobson J. A quick test of cognitive speed: Patterns of age groups 15 to 95 years. Percept Mot Skills 2007;104:1067–75.
   PubMed Web of Science ®Google Scholar
• Nielsen NP, Wiig EH. An additive model for relations between AQT single- and dual-dimension naming speed. Percept Mot Skills 2011;112:499–508.
   PubMed Web of Science ®Google Scholar
• Nielsen NP, Ringström R, Wiig EH, Minthon L. Associations between AQT processing speed and neuropsychological tests in neuropsychiatric patients. Am J Alzheimers Dis Other Demen 2007;22:202–10.
   PubMedGoogle Scholar
• Esterman M, Chui Y, Tamber-Rosenau BJ, Yantis S. Decoding cognitive control in human parietal cortex. Proc Natl Acad Sci USA 2009;106:17974–9.
   PubMed Web of Science ®Google Scholar
• Bueno VF, da Silva MA, Alves TM, Louzã MR, Pompéia S. Fractioning executive functions in adults with ADHD. J Atten Disord 2014;18:1–12. pii:1087054714545537.
   Google Scholar
• Nielsen NP, Wiig EH. AQT cognitive speed and processing efficiency differentiate adults with and without ADHD: A preliminary study. Int J Psychiatry Clin Pract 2011;15:219–27.
   PubMed Web of Science ®Google Scholar
• Wiig EH, Nielsen NP. A quick test of cognitive speed for comparing processing speed to differentiate adult psychiatric referrals with and without attention-deficit/hyperactivity disorders. Prim Care Companion CNS Disord 2012;14:pii: PCC.11m01273. doi: 10.4088/PCC.11m01273.
   PubMedGoogle Scholar
• Nielsen NP, Wiig EH. Validation of the AQT color-form additive model for screening and monitoring pharmacological treatment of ADHD. J Atten Disord 2013;17:187–93.
   PubMed Web of Science ®Google Scholar
• Brown T, Brown ADD. Scales (Swedish Translation). Stockholm: NCS Pearson; 2004.
   Google Scholar
• Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, et al. The World Health Organization adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population). Psychol Med 2005;35:245–56.
   PubMed Web of Science ®Google Scholar
• Wechsler D; WAIS IV: Wechsler adult intelligence scale. 4th ed. Swedish Version. Stockholm: NCS Pearson Inc; 2010.
   Google Scholar
• Delis DC, Kaplan E, Kramer JH. D-KEFS: Delis-Kaplan Executive Function System. Swedish Version. Stockholm: Harcourt Assessment, Inc; 2005.
   Google Scholar
• Leark RA, Greenberg LM, Kindschi CL, Dupuy TR, Hughes SJ; Test of Variables of Attention (T.O.V.A.). Los Alamitos, CA: The TOVA Company; 2007.
   Google Scholar
• Patrick KS, Markowitz JS. Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorder. Human Psychopharmacol 1997;12:527–46.
   Web of Science ®Google Scholar
• Wigel SB, Kupper RJ. A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention deficit/hyperactivity. J Child Adolesc Psychopharmacol 2014;24:562–9.
   PubMed Web of Science ®Google Scholar
• Kim S, Chen S, Tannock R. Visual function and color vision in adults with attention-deficit/hyperactivity disorder. J Optom 2014;7:22–36.
   PubMedGoogle Scholar